Nephrology

Headache Relief Shampoo Voted #1 Best New Product in 2019

headache relief shampoo bottles

Dr. D’s Medicated Headache Relief Shampoo is now available. This medicated shampoo will help alleviate headaches simply by soaking it on your head. Finding relief from minor to severe headaches shouldn’t always involve reaching for a bottle of pills. Dr. D is here to give you another option. Our proprietary formula will leave your head feeling better.

BUY NOW! http://headachereliefshampoo.com/product/headache-relief-shampoo/

January 1, 2019Comments OffHeadache Drug Trial | Headache Relief | Headache Shampoo | Headache Study | Headache Therapy
An Investigational Study to Evaluate the Safety and Effectiveness of BMS-986165 With Background Treatment in Participants With Lupus Nephritis

Condition:   Lupus Nephritis
Interventions:   Drug: BMS-986165;   Drug: Placebo
Sponsor:   Bristol-Myers Squibb
Recruiting
ClinicalTrials.gov: Nephrology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

June 4, 2019Comments OffBackground | BMS986165 | Effectiveness | Evaluate | Investigational | Lupus | Nephritis | Participants | Safety | Study | Treatment
A Trial of Bardoxolone Methyl in Patients With ADPKD – FALCON

Conditions:   Autosomal Dominant Polycystic Kidney;   ADPKD
Interventions:   Drug: Bardoxolone methyl oral capsule;   Drug: Placebo oral capsule
Sponsor:   Reata Pharmaceuticals, Inc.
Recruiting
ClinicalTrials.gov: Nephrology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

June 3, 2019Comments OffADPKD | Bardoxolone | FALCON | Methyl | Patients | Trial
A Study to Identify Participants With Advanced Urothelial Cancer and Fibroblast Growth Factor Receptor Gene Aberrations

Conditions:   Urothelial Cancer;   Receptors, Fibroblast Growth Factor
Intervention:   Other: Archival Tumor Tissue Sample
Sponsor:   Janssen Research & Development, LLC
Not yet recruiting
ClinicalTrials.gov: Nephrology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

May 24, 2019Comments OffAberrations | Advanced | Cancer | Factor | Fibroblast | Gene | Growth | Identify | Participants | Receptor | Study | Urothelial
Trial to Evaluate Reduction in Inflammation in Patients With Advanced Chronic Renal Disease Utilizing Antibody Mediated IL-6 Inhibition

Conditions:   Chronic Kidney Diseases;   Inflammation
Intervention:   Biological: Ziltivekimab
Sponsor:   Corvidia Therapeutics
Not yet recruiting
ClinicalTrials.gov: Nephrology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

May 21, 2019Comments OffAdvanced | Antibody | Chronic | Disease | Evaluate | Inflammation | Inhibition | Mediated | Patients | Reduction | Renal | Trial | Utilizing
Belimumab With Rituximab for Primary Membranous Nephropathy

Conditions:   Membranous Nephropathy;   MN
Interventions:   Drug: Belimumab;   Drug: Placebo for Belimumab;   Drug: Rituximab
Sponsors:   National Institute of Allergy and Infectious Diseases (NIAID);   Immune Tolerance Network (ITN)
Not yet recruiting
ClinicalTrials.gov: Nephrology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

May 14, 2019Comments OffBelimumab | Membranous | Nephropathy | Primary | Rituximab
Be-HealthY: Behavioral Risk Factors for Poor Vascular Health in Youth

Conditions:   Prehypertension;   Hypertension;   Overweight and Obesity;   Elevated Blood Pressure;   Endothelial Dysfunction;   Vascular Stiffness;   Sleep
Interventions:   Diagnostic Test: Cardiovascular Assessments;   Diagnostic Test: Actigraphy;   Diagnostic Test: Laboratory assessments
Sponsors:   Johns Hopkins University;   National Heart, Lung, and Blood Institute (NHLBI)
Recruiting
ClinicalTrials.gov: Nephrology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

May 1, 2019Comments OffBehavioral | BeHealthY | Factors | Health | Poor | Risk | Vascular | Youth
Uric Acid Lowering Trial in Youth Onset T2D

Conditions:   Diabetic Kidney Disease;   Hyperuricemia;   Diabetes;   Diabetes Mellitus, Type 2;   Type2 Diabetes;   Type 2 Diabetes Mellitus;   Diabetic Nephropathies;   Diabetes Complications
Intervention:   Drug: Pegloticase 8 MG/ML [Krystexxa]
Sponsor:   University of Colorado Denver School of Medicine Barbara Davis Center
Not yet recruiting
ClinicalTrials.gov: Nephrology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

April 3, 2019Comments OffAcid | Lowering | Onset | Trial | Uric | Youth
Chronic Kidney Disease Clinical Decision Support

Conditions:   Chronic Kidney Diseases;   Hypertension;   Diabetes
Intervention:   Other: CKD enhanced clinical decision support
Sponsors:   HealthPartners Institute;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Not yet recruiting
ClinicalTrials.gov: Nephrology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

March 27, 2019Comments OffChronic | Clinical | Decision | Disease | Kidney | Support
Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa

Conditions:   Anemia;   Dialysis-dependent Chronic Kidney Disease
Interventions:   Drug: Vadadustat;   Drug: Epoetin Alfa;   Drug: Vadadustat TIW
Sponsor:   Akebia Therapeutics
Recruiting
ClinicalTrials.gov: Nephrology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

March 23, 2019Comments OffAlfa | Anemia | Epoetin | From | Hemodialysis | Patients | Study | Switching | Vadadustat
Pulse Wave Velocity, Tacrolimus Time in Therapeutic Range and CV in African American Kidney Transplants

Condition:   Kidney Transplant; Complications
Interventions:   Drug: Extended Release Tacrolimus Tablets;   Drug: Immediate Release Tacrolimus Capsule
Sponsors:   Roy D. Bloom, MD;   Veloxis Pharmaceuticals
Not yet recruiting
ClinicalTrials.gov: Nephrology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

February 15, 2019Comments OffAfrican | American | Kidney | Pulse | Range | Tacrolimus | Therapeutic | Time | Transplants | Velocity | Wave